CDKN2A and neoplasm: Only one tumor (1/9, 11%) demonstrated focal amplification of PDGFRA on chromosome 4q12, and only one tumor (1/9, 11%) demonstrated focal homozygous/biallelic deletion of CDKN2A and CDKN2B on chromosome 9p21.